초록 ▼

Apparatus and methods deliver vasoconstrictive agents simultaneously with capnic gases. The capnic gases can enhance the effectiveness of the vasoconstrictive agent, lower the dosage of drug or concentration of agent necessary to achieve a therapeutic result, or both. Exemplary capnic gases include

Apparatus and methods deliver vasoconstrictive agents simultaneously with capnic gases. The capnic gases can enhance the effectiveness of the vasoconstrictive agent, lower the dosage of drug or concentration of agent necessary to achieve a therapeutic result, or both. Exemplary capnic gases include carbon dioxide, nitric oxide, nitrous oxide, and dilute acid gases.

대표청구항 ▼

1. A method for treating a migraine headache in a patient, said method comprising: systemically administering a migraine medication to a patient in need thereof, anddelivering a capnic gas comprising carbon dioxide to a nasal or oral membrane of the patient while the patient refrains from inhaling t

1. A method for treating a migraine headache in a patient, said method comprising: systemically administering a migraine medication to a patient in need thereof, anddelivering a capnic gas comprising carbon dioxide to a nasal or oral membrane of the patient while the patient refrains from inhaling the capnic gas;wherein the migraine medication and the capnic gas are administered and delivered within 60 minutes of each other. 2. The method according to claim 1, wherein the migraine medication is a vasoconstrictive agent. 3. The method according to claim 2, wherein the vasoconstrictive agent comprises a triptan or an ergotamine. 4. The method according to claim 3, wherein the triptan is sumatriptan, zolmitriptan, rizatriptan, almotriptan, naratriptan, electriptan, or frovatriptan. 5. The method according to claim 3, wherein the ergotamine is ergotamine tartrate or dihydroergotamine DHE-45. 6. The method according to claim 1, wherein the migraine medication is selected from the group consisting of a 5-HT ligand, an alpha-adrenergic ligand, an anticonvulsant, a tricyclic antidepressant, a selective serotonin reuptake inhibitor, a monoamine oxidase (MAO) inhibitor, a calcium channel blocker, and lithium carbonate. 7. The method according to claim 1, wherein the capnic gas is infused through a nostril and exits through a nostril and/or the mouth. 8. The method according to claim 1, wherein the capnic gas is infused through the mouth and exits through at least one nostril. 9. The method according to claim 1, wherein the capnic gas comprises carbon dioxide at a concentration of at least 50% by volume. 10. The method according to claim 9, wherein the capnic gas comprises carbon dioxide at a concentration of at least 80% by volume. 11. The method according to claim 10, wherein the carbon dioxide is substantially pure. 12. The method according to claim 9, wherein the capnic gas is delivered at a controlled flow rate in the range from 0.5 to 30 cc/sec. 13. The method according to claim 1, wherein the migraine medication and the capnic gas are administered and delivered within 30 minutes of each other. 14. The method according to claim 1, wherein the migraine medication and the capnic gas are administered and delivered within 10 minutes of each other.